Wanjia Group Holdings Ltd. wholesales and distributes pharmaceutical and healthcare products. It operates through following segments: Pharmaceutical Wholesale and Distribution Business; Pharmaceutical Retail Chain Business; and Hemodialysis Treatment and Consultancy Service Business. The Pharmaceutical Wholesale and Distribution Business segment provides wholesale and distribution, logistics, and other services for a range of pharmaceutical products of domestic manufacturers and other suppliers. The Pharmaceutical Retail Business segment operates a chain of retail pharmacies located in China under the brand name Huihao Sihai. The Hemodialysis Treatment and Consultancy Service Business segment includes hemodialysis treatment centers and supplies hemodialysis treatment consumables and equipment. The company was founded on July 9, 2012 and is headquartered in Hong Kong.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company